KHAN NAJAT (CEO and President) received a stock award from RECURSION PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/6/2025ACC: 0002020969-25-000004
DirectorOfficer· CEO and President
Since Feb 2026
+254.78K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
254.78K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+84.92K
Price / share
—
Trade value
—
% of position
12.7%
11/5/2025
668.20K→753.12K
Total
Net shares
+84.92K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 11/5/2025 | A · Award | +84.92K | — | — | 12.7% | 668.20K | 753.12K |
| Total | +84.92K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Class A Common Stock
169.85K shares
Shares
+169.85K
Strike price
4.96
Held after
169.85K
Exercisable
—
11/5/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Class A Common Stock169.85K shares | 11/5/2025 | A · Award | +169.85K | 4.96 | — | 169.85K |